| Code | 9922D | ||||||||||
| MA number | 64/0002/19-S | ||||||||||
| Product Form: | int opo 4x2,5 ml (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Bausch + Lomb Ireland Limited, Ireland | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 18.01.2019 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Vizilatan 0,05 mg ml_10.2023.pdf
|
| SPC: |
SPC_Vizilatan 0,05 mg ml_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 05.01.2024 |
